vs
Side-by-side financial comparison of 4D Molecular Therapeutics, Inc. (FDMT) and NPK International Inc. (NPKI). Click either name above to swap in a different company.
4D Molecular Therapeutics, Inc. is the larger business by last-quarter revenue ($85.1M vs $75.2M, roughly 1.1× NPK International Inc.). On growth, 4D Molecular Therapeutics, Inc. posted the faster year-over-year revenue change (8508900.0% vs 30.7%). 4D Molecular Therapeutics, Inc. produced more free cash flow last quarter ($28.5M vs $5.8M). Over the past eight quarters, 4D Molecular Therapeutics, Inc.'s revenue compounded faster (5412.6% CAGR vs 23.9%).
4D Molecular Therapeutics is a clinical-stage biotechnology company specializing in the research and development of targeted adeno-associated virus (AAV) gene therapies. Its core product candidates address unmet medical needs in ophthalmology, cardiology, and pulmonary disease segments, serving global patient populations with rare and common hard-to-treat conditions.
FDMT vs NPKI — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $85.1M | $75.2M |
| Net Profit | $19.4M | — |
| Gross Margin | — | 37.7% |
| Operating Margin | 17.3% | 16.7% |
| Net Margin | 22.8% | — |
| Revenue YoY | 8508900.0% | 30.7% |
| Net Profit YoY | 139.1% | — |
| EPS (diluted) | $0.43 | $0.17 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $85.1M | $75.2M | ||
| Q3 25 | $90.0K | $68.8M | ||
| Q2 25 | $15.0K | $68.2M | ||
| Q1 25 | $14.0K | $64.8M | ||
| Q4 24 | $1.0K | $57.5M | ||
| Q3 24 | $3.0K | $44.2M | ||
| Q2 24 | $5.0K | $66.8M | ||
| Q1 24 | $28.0K | $49.0M |
| Q4 25 | $19.4M | — | ||
| Q3 25 | $-56.9M | $5.7M | ||
| Q2 25 | $-54.7M | $8.7M | ||
| Q1 25 | $-48.0M | $10.0M | ||
| Q4 24 | — | — | ||
| Q3 24 | $-43.8M | $-174.3M | ||
| Q2 24 | $-35.0M | $8.0M | ||
| Q1 24 | $-32.4M | $7.3M |
| Q4 25 | — | 37.7% | ||
| Q3 25 | — | 31.9% | ||
| Q2 25 | — | 36.9% | ||
| Q1 25 | — | 39.0% | ||
| Q4 24 | — | 39.2% | ||
| Q3 24 | — | 27.5% | ||
| Q2 24 | — | 37.2% | ||
| Q1 24 | — | 36.0% |
| Q4 25 | 17.3% | 16.7% | ||
| Q3 25 | -67983.3% | 13.2% | ||
| Q2 25 | -396373.3% | 17.0% | ||
| Q1 25 | -383007.1% | 20.9% | ||
| Q4 24 | — | 20.2% | ||
| Q3 24 | -1704400.0% | 2.8% | ||
| Q2 24 | -849120.0% | 18.7% | ||
| Q1 24 | -136200.0% | 14.2% |
| Q4 25 | 22.8% | — | ||
| Q3 25 | -63195.6% | 8.2% | ||
| Q2 25 | -364386.7% | 12.7% | ||
| Q1 25 | -342657.1% | 15.4% | ||
| Q4 24 | — | — | ||
| Q3 24 | -1461433.3% | -394.3% | ||
| Q2 24 | -699060.0% | 12.0% | ||
| Q1 24 | -115717.9% | 14.9% |
| Q4 25 | $0.43 | $0.17 | ||
| Q3 25 | $-1.01 | $0.07 | ||
| Q2 25 | $-0.98 | $0.10 | ||
| Q1 25 | $-0.86 | $0.11 | ||
| Q4 24 | — | $0.10 | ||
| Q3 24 | $-0.79 | $-1.99 | ||
| Q2 24 | $-0.63 | $0.09 | ||
| Q1 24 | $-0.66 | $0.08 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $402.7M | $5.1M |
| Total DebtLower is stronger | — | $16.9M |
| Stockholders' EquityBook value | $505.7M | $351.2M |
| Total Assets | $566.7M | $441.8M |
| Debt / EquityLower = less leverage | — | 0.05× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $402.7M | $5.1M | ||
| Q3 25 | $305.1M | $35.6M | ||
| Q2 25 | $293.2M | $26.0M | ||
| Q1 25 | $321.4M | $20.8M | ||
| Q4 24 | $424.9M | $17.8M | ||
| Q3 24 | $501.9M | $42.9M | ||
| Q2 24 | $541.9M | $35.1M | ||
| Q1 24 | $525.9M | $37.7M |
| Q4 25 | — | $16.9M | ||
| Q3 25 | — | $9.5M | ||
| Q2 25 | — | $9.3M | ||
| Q1 25 | — | $8.1M | ||
| Q4 24 | — | $7.7M | ||
| Q3 24 | — | $14.0M | ||
| Q2 24 | — | $58.0M | ||
| Q1 24 | — | $77.4M |
| Q4 25 | $505.7M | $351.2M | ||
| Q3 25 | $369.0M | $333.9M | ||
| Q2 25 | $420.9M | $328.8M | ||
| Q1 25 | $469.7M | $326.9M | ||
| Q4 24 | $510.6M | $326.5M | ||
| Q3 24 | $552.9M | $316.5M | ||
| Q2 24 | $588.3M | $426.6M | ||
| Q1 24 | $600.6M | $421.6M |
| Q4 25 | $566.7M | $441.8M | ||
| Q3 25 | $424.0M | $404.5M | ||
| Q2 25 | $473.6M | $393.7M | ||
| Q1 25 | $515.7M | $390.0M | ||
| Q4 24 | $560.4M | $393.7M | ||
| Q3 24 | $604.0M | $389.6M | ||
| Q2 24 | $620.1M | $624.8M | ||
| Q1 24 | $629.9M | $640.8M |
| Q4 25 | — | 0.05× | ||
| Q3 25 | — | 0.03× | ||
| Q2 25 | — | 0.03× | ||
| Q1 25 | — | 0.02× | ||
| Q4 24 | — | 0.02× | ||
| Q3 24 | — | 0.04× | ||
| Q2 24 | — | 0.14× | ||
| Q1 24 | — | 0.18× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $28.6M | $18.0M |
| Free Cash FlowOCF − Capex | $28.5M | $5.8M |
| FCF MarginFCF / Revenue | 33.5% | 7.6% |
| Capex IntensityCapex / Revenue | 0.1% | 16.3% |
| Cash ConversionOCF / Net Profit | 1.47× | — |
| TTM Free Cash FlowTrailing 4 quarters | $-109.9M | $26.3M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $28.6M | $18.0M | ||
| Q3 25 | $-46.5M | $24.7M | ||
| Q2 25 | $-43.4M | $21.4M | ||
| Q1 25 | $-47.8M | $8.8M | ||
| Q4 24 | $-134.6M | $-4.1M | ||
| Q3 24 | $-29.4M | $2.8M | ||
| Q2 24 | $-30.2M | $27.6M | ||
| Q1 24 | $-29.1M | $11.9M |
| Q4 25 | $28.5M | $5.8M | ||
| Q3 25 | $-46.6M | $12.0M | ||
| Q2 25 | $-43.4M | $9.7M | ||
| Q1 25 | $-48.4M | $-1.2M | ||
| Q4 24 | $-138.4M | $-17.7M | ||
| Q3 24 | $-31.2M | $-6.7M | ||
| Q2 24 | $-30.6M | $21.0M | ||
| Q1 24 | $-29.8M | $-1.9M |
| Q4 25 | 33.5% | 7.6% | ||
| Q3 25 | -51765.6% | 17.4% | ||
| Q2 25 | -289620.0% | 14.3% | ||
| Q1 25 | -345635.7% | -1.8% | ||
| Q4 24 | -13837100.0% | -30.8% | ||
| Q3 24 | -1038966.7% | -15.2% | ||
| Q2 24 | -611840.0% | 31.4% | ||
| Q1 24 | -106421.4% | -3.9% |
| Q4 25 | 0.1% | 16.3% | ||
| Q3 25 | 101.1% | 18.5% | ||
| Q2 25 | 440.0% | 17.1% | ||
| Q1 25 | 4507.1% | 15.5% | ||
| Q4 24 | 378600.0% | 23.6% | ||
| Q3 24 | 59266.7% | 21.4% | ||
| Q2 24 | 6980.0% | 9.9% | ||
| Q1 24 | 2535.7% | 28.3% |
| Q4 25 | 1.47× | — | ||
| Q3 25 | — | 4.37× | ||
| Q2 25 | — | 2.47× | ||
| Q1 25 | — | 0.88× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 3.43× | ||
| Q1 24 | — | 1.64× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
FDMT
Segment breakdown not available.
NPKI
| Rental Revenue | $34.8M | 46% |
| Products | $25.5M | 34% |
| Services | $14.9M | 20% |
